CIK: 0002103725
Total reported value
$119.7M
Reporting period: 2026-03-31 · Number of holdings: 5
AIHC Capital Management Ltd disclosed 5 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $119.7M and a quarterly turnover rate of 66.4%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "A"
AIHC Capital Management Ltd's disclosed holdings carry a Herfindahl concentration index of 0.524 — mathematically equivalent to about 2 equally-sized positions, well below its 5 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.42), with a handful of outsized bets alongside many smaller positions.
Recent activity leans toward initiating meaningfully larger new positions than it adds to existing ones (a 24.5 percentage-point tilt) — a pattern consistent with a more contrarian, new-idea-driven approach.
Sector classification currently covers about 67% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add NBP
+446.6% $3.9M
Trim COGT
-48.6% -$1.6M
Add RVMD
-7.9% $8.9M
Add KRRO
0.0% $100.2K
New buy ORIC
Sold out PTGX
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | Stock-Healthcare | 67.37% | +0.16% | -7.93% | |
| 2 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 26.04% | +26.04% | NEW | |
| 3 | NBP | Novabridge Biosciences | Stock-Other | 4.65% | +3.11% | +446.63% | |
| 4 | COGT | Cogent Biosciences INC | Stock-Other | 1.65% | -1.68% | -48.60% | |
| 5 | KRRO | Korro Bio INC | Stock-Other | 0.29% | +0.06% | — |
Performance for Q3 2026
+25.9%
Performance Last 4 Quarters
+69.3%
Based on 5 months of available history
Based on 69% of reported portfolio value with available pricing
AIHC Capital Management Ltd's most significant position changes for 2026-03-31: New buy: Oric Pharmaceuticals INC (ORIC); Sold out: Protagonist Therapeutics INC (PTGX); Sold out: Arrivent Biopharma INC (AVBP); Add: Novabridge Biosciences (NBP) — shares +446.63%; Trim: Cogent Biosciences INC (COGT) — shares -48.60%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NBP | Novabridge Biosciences | +3.1% | +446.63% | Add |
| 2 | RVMD | Revolution Medicines INC | +0.2% | -7.93% | Trim |
| 3 | KRRO | Korro Bio INC | +0.1% | — | Unchanged |
| 4 | COGT | Cogent Biosciences INC | -1.7% | -48.60% | Trim |
| 5 | ORIC | Oric Pharmaceuticals INC | — | NEW | New buy |
| 6 | PTGX | Protagonist Therapeutics INC | — | EXIT | Sold out |
| 7 | AVBP | Arrivent Biopharma INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-08 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-05 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001739953
Total reported value
$119.7M
82 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001907208
Total reported value
$119.6M
17 stks
2023-12-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0002116771
Total reported value
$119.6M
53 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001595430
Total reported value
$1.4B
17 stks
2026-03-31
2 of the top 5 holdings overlap, including Revolution Medicines INC
CIK 0001833486
Total reported value
$100.7M
3 stks
2026-03-31
2 of the top 5 holdings overlap, including Oric Pharmaceuticals INC
CIK 0001911010
Total reported value
$616.4M
15 stks
2024-12-31
Stale — no recent filing
2 of the top 5 holdings overlap, including Revolution Medicines INC